Literature DB >> 28668117

Expression and Structural Analyses of Human DNA Polymerase θ (POLQ).

Andrew W Malaby1, Sara K Martin2, Richard D Wood2, Sylvie Doublié3.   

Abstract

DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes. Pol θ is the defining enzyme for a pathway of DSB repair termed "alternative end-joining" (altEJ) or "theta-mediated end-joining." This pathway contributes significantly to the radiation resistance of mammalian cells. It also modulates accuracy in repair of breaks that occur at stalled DNA replication forks, during diversification steps of the mammalian immune system, during repair of CRISPR-Cas9, and in many DNA integration events. Pol θ is a potentially important clinical target, particularly for cancers deficient in other break repair strategies. The enzyme is uniquely able to mediate joining of single-stranded 3' ends. Because of these unusual biochemical properties and its therapeutic importance, it is essential to study structures of pol θ bound to DNA. However, challenges for expression and purification are presented by the large size of pol θ (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered). Here we summarize work on the expression and purification of the full-length protein, and then focus on the design, expression, and purification of an active C-terminal polymerase fragment. The generation of this active construct was nontrivial and time consuming. Almost all published biochemical work to date has been performed with this domain fragment. Strategies to obtain and improve crystals of a ternary pol θ complex (enzyme:DNA:nucleotide) are also presented, along with key elements of the structure.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative end-joining; DNA double-strand breaks; DNA polymerase; DNA synthesis

Mesh:

Substances:

Year:  2017        PMID: 28668117      PMCID: PMC5624038          DOI: 10.1016/bs.mie.2017.03.026

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  51 in total

1.  Structures of human DNA polymerases ν and θ expose their end game.

Authors:  William A Beard; Samuel H Wilson
Journal:  Nat Struct Mol Biol       Date:  2015-04       Impact factor: 15.369

2.  Crystallization of Pseudomonas aeruginosa AmrZ protein: development of a comprehensive method for obtaining and optimization of protein-DNA crystals.

Authors:  Edward E Pryor; Daniel J Wozniak; Thomas Hollis
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

Review 3.  DNA polymerase POLQ and cellular defense against DNA damage.

Authors:  Matthew J Yousefzadeh; Richard D Wood
Journal:  DNA Repair (Amst)       Date:  2012-12-04

4.  DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct.

Authors:  Mineaki Seki; Richard D Wood
Journal:  DNA Repair (Amst)       Date:  2007-10-24

5.  Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ.

Authors:  Tatiana Kent; Gurushankar Chandramouly; Shane Michael McDevitt; Ahmet Y Ozdemir; Richard T Pomerantz
Journal:  Nat Struct Mol Biol       Date:  2015-02-02       Impact factor: 15.369

6.  How a homolog of high-fidelity replicases conducts mutagenic DNA synthesis.

Authors:  Young-Sam Lee; Yang Gao; Wei Yang
Journal:  Nat Struct Mol Biol       Date:  2015-03-16       Impact factor: 15.369

7.  Protein interface classification by evolutionary analysis.

Authors:  Jose M Duarte; Adam Srebniak; Martin A Schärer; Guido Capitani
Journal:  BMC Bioinformatics       Date:  2012-12-22       Impact factor: 3.169

8.  Analysis Tool Web Services from the EMBL-EBI.

Authors:  Hamish McWilliam; Weizhong Li; Mahmut Uludag; Silvano Squizzato; Young Mi Park; Nicola Buso; Andrew Peter Cowley; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2013-05-13       Impact factor: 16.971

9.  Low-fidelity DNA synthesis by human DNA polymerase theta.

Authors:  Mercedes E Arana; Mineaki Seki; Richard D Wood; Igor B Rogozin; Thomas A Kunkel
Journal:  Nucleic Acids Res       Date:  2008-05-24       Impact factor: 16.971

10.  Polymerase θ is a robust terminal transferase that oscillates between three different mechanisms during end-joining.

Authors:  Tatiana Kent; Pedro A Mateos-Gomez; Agnel Sfeir; Richard T Pomerantz
Journal:  Elife       Date:  2016-06-17       Impact factor: 8.140

View more
  7 in total

1.  Polymerase theta-helicase promotes end joining by stripping single-stranded DNA-binding proteins and bridging DNA ends.

Authors:  Jeffrey M Schaub; Michael M Soniat; Ilya J Finkelstein
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

2.  Expanded Substrate Scope of DNA Polymerase θ and DNA Polymerase β: Lyase Activity on 5'-Overhangs and Clustered Lesions.

Authors:  Daniel J Laverty; Marc M Greenberg
Journal:  Biochemistry       Date:  2018-10-09       Impact factor: 3.162

3.  Human DNA polymerase θ harbors DNA end-trimming activity critical for DNA repair.

Authors:  Karl E Zahn; Ryan B Jensen; Richard D Wood; Sylvie Doublié
Journal:  Mol Cell       Date:  2021-02-11       Impact factor: 17.970

Review 4.  Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions.

Authors:  Vinit Shanbhag; Shrikesh Sachdev; Jacqueline A Flores; Mukund J Modak; Kamalendra Singh
Journal:  Biology (Basel)       Date:  2018-01-02

5.  Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in Leishmania.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

Review 6.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09

7.  Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.

Authors:  Diana Zatreanu; Helen M R Robinson; Omar Alkhatib; Marie Boursier; Harry Finch; Lerin Geo; Diego Grande; Vera Grinkevich; Robert A Heald; Sophie Langdon; Jayesh Majithiya; Claire McWhirter; Niall M B Martin; Shaun Moore; Joana Neves; Eeson Rajendra; Marco Ranzani; Theresia Schaedler; Martin Stockley; Kimberley Wiggins; Rachel Brough; Sandhya Sridhar; Aditi Gulati; Nan Shao; Luned M Badder; Daniela Novo; Eleanor G Knight; Rebecca Marlow; Syed Haider; Elsa Callen; Graeme Hewitt; Joost Schimmel; Remko Prevo; Christina Alli; Amanda Ferdinand; Cameron Bell; Peter Blencowe; Chris Bot; Mathew Calder; Mark Charles; Jayne Curry; Tennyson Ekwuru; Katherine Ewings; Wojciech Krajewski; Ellen MacDonald; Hollie McCarron; Leon Pang; Chris Pedder; Laurent Rigoreau; Martin Swarbrick; Ed Wheatley; Simon Willis; Ai Ching Wong; Andre Nussenzweig; Marcel Tijsterman; Andrew Tutt; Simon J Boulton; Geoff S Higgins; Stephen J Pettitt; Graeme C M Smith; Christopher J Lord
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.